RetractedArticleCellular & molecular biology letters2022

Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1-AKT pathway.

Han-Ming Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.